Trial intelligence / Profile preview

Quetiapine vs Haloperidol for Methamphetamine-Induced Psychosis

NCT01939093Phase 4Completed

Sponsor
Chulalongkorn University
Start
Mar 2010
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in methamphetamine-induced psychosis, sponsored by Chulalongkorn University. Started Mar 2010; status: completed.

02

Drugs

quetiapine (extended-release tablet, brand name: Bipresso)
03

Conditions

methamphetamine-induced psychosis

Beyond the preview

Go deeper on NCT01939093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01939093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call